Registration obtained for Airing™ in Moldova
In January 2022 marketing authorization was received in Moldova for Airing™. Airing™ has been licensed from Mithra (Belgium) and is a generic version of Nuvaring™, a hormonal contraceptive vaginal ring. Market introduction is expected for the second half of 2023. About Airing™ Airing™ (etonogestrel/ethinyl estradiol vaginal ring) is a non-biodegradable, flexible, transparent, combination contraceptive vaginal […]
Registration obtained for Aivial™ in Moldova
Aicore Life Science, Netherlands, obtained marketing authorization in Moldova for Aivial™ in November 2021. Market introductions are expected in the second half of 2023. About Aivial™ Aivial™ is a synthetic steroid (tibolone) intended to be used for hormone replacement therapy. Aivial is a bioequivalent of Livial® 2.5mg which is a product that mimics the activity […]
Registration obtained for Aivial™ in Bulgaria
Aicore Life Science, Netherlands in November 2021 obtained marketing authorization in Bulgaria for Aivial™. Market introductions are expected in the second half of 2023. About Aivial™ Aivial™ is a synthetic steroid (tibolone) intended to be used for hormone replacement therapy. Aivial is a bioequivalent of Livial® 2.5mg which is a product that mimics the activity […]
Aicore starts cooperation with Aurea Pharma
Aicore starts cooperation with Aurea Pharma company, focused on developing and providing patients with specialist products for skincare during and after radiotherapy and chemotherapy
Aicore begins cooperation with Aurena Laboratories
Aurena Laboratories (Sweden), a pioneer in implementing the Bag on Valve technology, starts developing a new product line for Aicore under the brand NORMARIN®